Infarct size in a rat model of STEMI is reduced by interleukin-6 trans-signalling blockade using sgp130fc but not an anti-IL6R monoclonal antibody
Event:
ESC Congress 2017
Topic:
Inflammation and microcirculation
Session:
CAD: role of inflammation and immunity
